These findings also suggest an alternative model for the development of pathological cardiac hypertrophy and a novel putative pharmacological target, as increasing Herpud1 levels may prevent or revert pathological cardiac hypertrophy and myocardial dysfunction. This evidence concerns the gene HERPUD1 and cardiac hypertrophy.